The Role of PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma Metabolism
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Role of PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma Metabolism
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 24, Issue 3, Pages 2652
Publisher
MDPI AG
Online
2023-01-31
DOI
10.3390/ijms24032652
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- VLCAD inhibits the proliferation and invasion of hepatocellular cancer cells through regulating PI3K/AKT axis
- (2022) QW Zhu et al. Clinical & Translational Oncology
- PET-Based Radiogenomics Supports mTOR Pathway Targeting for Hepatocellular Carcinoma
- (2022) Jihyun AN et al. CLINICAL CANCER RESEARCH
- Phase II Study of Copanlisib in Patients With Tumors With PIK3CA Mutations: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1F
- (2022) Senthil Damodaran et al. JOURNAL OF CLINICAL ONCOLOGY
- HBx increases chromatin accessibility and ETV4 expression to regulate dishevelled-2 and promote HCC progression
- (2022) Chuqian Zheng et al. Cell Death & Disease
- UBE2T-mediated Akt ubiquitination and Akt/β-catenin activation promotes hepatocellular carcinoma development by increasing pyrimidine metabolism
- (2022) Zhenru Zhu et al. Cell Death & Disease
- Repressing phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma by microRNA-142-3p restrains the progression of hepatocellular carcinoma
- (2022) Chuanli Zeng et al. Bioengineered
- Cancer Genomic Alterations Can Be Potential Biomarkers Predicting Microvascular Invasion and Early Recurrence of Hepatocellular Carcinoma
- (2022) Zhaodan Xin et al. Frontiers in Oncology
- Metabolic tricks of cancer cells
- (2022) Katerina Hönigova et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Circ-ZEB1 promotes PIK3CA expression by silencing miR-199a-3p and affects the proliferation and apoptosis of hepatocellular carcinoma
- (2022) Weiwei Liu et al. Molecular Cancer
- H3K9me3 represses G6PD expression to suppress the pentose phosphate pathway and ROS production to promote human mesothelioma growth
- (2022) Chunwan Lu et al. ONCOGENE
- PI3K/Akt/mTOR Pathway and Its Role in Cancer Therapeutics: Are We Making Headway?
- (2022) Yan Peng et al. Frontiers in Oncology
- Novel Paired Cell Lines for the Study of Lipid Metabolism and Cancer Stemness of Hepatocellular Carcinoma
- (2022) Yun-Hsin Cheng et al. Frontiers in Cell and Developmental Biology
- The Role of mTOR Signaling as a Therapeutic Target in Cancer
- (2021) Nadezhda V. Popova et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Key Enzymes in Pyrimidine Synthesis, CAD and CPS1, Predict Prognosis in Hepatocellular Carcinoma
- (2021) Dirk Andreas Ridder et al. Cancers
- The fatty acid receptor CD36 promotes HCC progression through activating Src/PI3K/AKT axis-dependent aerobic glycolysis
- (2021) Xiaoqing Luo et al. Cell Death & Disease
- Lactic acid in macrophage polarization: The significant role in inflammation and cancer
- (2021) Hai-cun Zhou et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- Arsenene-mediated multiple independently targeted reactive oxygen species burst for cancer therapy
- (2021) Na Kong et al. Nature Communications
- Loss of tyrosine catabolic enzyme HPD promotes glutamine anaplerosis through mTOR signaling in liver cancer
- (2021) Man Tong et al. Cell Reports
- Metabolic reprogramming of immune cells: Shaping the tumor microenvironment in hepatocellular carcinoma
- (2021) Yujia Xia et al. Cancer Medicine
- Targeting Pyrimidine Metabolism in the Era of Precision Cancer Medicine
- (2021) Wanyan Wang et al. Frontiers in Oncology
- Glutathione S-transferase A2 promotes hepatocellular carcinoma recurrence after liver transplantation through modulating reactive oxygen species metabolism
- (2021) Kevin Tak-Pan Ng et al. Cell Death Discovery
- Impact of intracellular innate immune receptors on immunometabolism
- (2021) Wei-Chun Chou et al. Cellular & Molecular Immunology
- Functional Mapping of AKT Signaling and Biomarkers of Response from the FAIRLANE Trial of Neoadjuvant Ipatasertib plus Paclitaxel for Triple-Negative Breast Cancer
- (2021) Zhen Shi et al. CLINICAL CANCER RESEARCH
- Why may citrate sodium significantly increase the effectiveness of transarterial chemoembolization in hepatocellular carcinoma?
- (2021) Philippe Icard et al. DRUG RESISTANCE UPDATES
- Sirolimus or Everolimus Improves Survival After Liver Transplantation for Hepatocellular Carcinoma: A Systematic Review and Meta‐Analysis
- (2021) Xiangyu Yan et al. LIVER TRANSPLANTATION
- Targeting cancer metabolism in the era of precision oncology
- (2021) Zachary E. Stine et al. NATURE REVIEWS DRUG DISCOVERY
- Activation of mTOR Signaling Pathway in Hepatocellular Carcinoma
- (2020) Gustavo Ferrín et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- NRF2 Activates Growth Factor Genes and Downstream AKT Signaling to Induce Mouse and Human Hepatomegaly
- (2020) Feng He et al. JOURNAL OF HEPATOLOGY
- A non-proliferative role of pyrimidine metabolism in cancer
- (2020) Aarif Siddiqui et al. Molecular Metabolism
- Energy metabolism and cell motility defect in NK-cells from patients with hepatocellular carcinoma
- (2020) Alessandra Zecca et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Why Warburg Works: Lactate Controls Immune Evasion through GPR81
- (2020) Kathrine Lundø et al. Cell Metabolism
- Metabolic reprogramming and cancer progression
- (2020) Brandon Faubert et al. SCIENCE
- TRIM21 and PHLDA3 negatively regulate the crosstalk between the PI3K/AKT pathway and PPP metabolism
- (2020) Jie Cheng et al. Nature Communications
- Virtual Screening and Optimization of Novel mTOR Inhibitors for Radiosensitization of Hepatocellular Carcinoma
- (2020) Ying-Qi Feng et al. Drug Design Development and Therapy
- p53 haploinsufficiency and increased mTOR signaling define a subset of aggressive hepatocellular carcinoma
- (2020) Yuan-Deng Luo et al. JOURNAL OF HEPATOLOGY
- PIK3C3 regulates the expansion of liver CSCs and PIK3C3 inhibition counteracts liver cancer stem cell activity induced by PI3K inhibitor
- (2020) Fengchao Liu et al. Cell Death & Disease
- A combination of AZD5363 and FH5363 induces lethal autophagy in transformed hepatocytes
- (2020) Tapas Patra et al. Cell Death & Disease
- Targeting Lipid Metabolism in Liver Cancer
- (2020) Malak Alannan et al. BIOCHEMISTRY
- Exploring the NK cell platform for cancer immunotherapy
- (2020) Jacob A. Myers et al. Nature Reviews Clinical Oncology
- Reactive Oxygen Species Induce Endothelial Differentiation of Liver Cancer Stem-Like Sphere Cells through the Activation of Akt/IKK Signaling Pathway
- (2020) Zhengbin Zhao et al. Oxidative Medicine and Cellular Longevity
- A powerful drug combination strategy targeting glutamine addiction for the treatment of human liver cancer
- (2020) Haojie Jin et al. eLife
- Polyphenolic Proanthocyanidin-B2 suppresses proliferation of liver cancer cells and hepatocellular carcinogenesis through directly binding and inhibiting AKT activity
- (2020) Guijun Liu et al. Redox Biology
- Non-metabolic role of UCK2 links EGFR-AKT pathway activation to metastasis enhancement in hepatocellular carcinoma
- (2020) Jie Cai et al. Oncogenesis
- β-Thujaplicin induces autophagic cell death, apoptosis, and cell cycle arrest through ROS-mediated Akt and p38/ERK MAPK signaling in human hepatocellular carcinoma
- (2019) Guangya Zhang et al. Cell Death & Disease
- Ursodeoxycholic acid ameliorates hepatic lipid metabolism in LO2 cells by regulating the AKT/mTOR/SREBP-1 signaling pathway
- (2019) Jie Hu et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Lamc1 promotes the Warburg effect in hepatocellular carcinoma cells by regulating PKM2 expression through AKT pathway
- (2019) GuanXiong Ye et al. CANCER BIOLOGY & THERAPY
- 6PGD inhibition sensitizes hepatocellular carcinoma to chemotherapy via AMPK activation and metabolic reprogramming
- (2019) Hu Chen et al. BIOMEDICINE & PHARMACOTHERAPY
- The mTORC 2‐Akt cascade is crucial for c‐Myc to promote hepatocarcinogenesis in mice and men
- (2019) Zhong Xu et al. HEPATOLOGY
- Capsaicin Targets Lipogenesis in HepG2 Cells Through AMPK Activation, AKT Inhibition and PPARs Regulation
- (2019) Alicia Bort et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Exosome-mediated communication in the tumor microenvironment contributes to hepatocellular carcinoma development and progression
- (2019) Qin Wu et al. Journal of Hematology & Oncology
- Class II PI3K Functions in Cell Biology and Disease
- (2019) Federico Gulluni et al. TRENDS IN CELL BIOLOGY
- Macrophages and Metabolism in the Tumor Microenvironment
- (2019) Ilio Vitale et al. Cell Metabolism
- Nqo1 ablation inhibits activation of the PI3K/Akt and MAPK/ERK pathways and blocks metabolic adaptation in hepatocellular carcinoma
- (2019) Manali Dimri et al. HEPATOLOGY
- GLS1 promotes proliferation in hepatocellular carcinoma cells via AKT/GSK3β/CyclinD1 pathway
- (2019) Jianbo Xi et al. EXPERIMENTAL CELL RESEARCH
- AKT1 internal tandem duplications and point mutations are the genetic hallmarks of sclerosing pneumocytoma
- (2019) Yi-Chen Yeh et al. MODERN PATHOLOGY
- Targeting pyrimidine synthesis accentuates molecular therapy response in glioblastoma stem cells
- (2019) Xiuxing Wang et al. Science Translational Medicine
- Hydrogen peroxide inducible clone-5 sustains NADPH oxidase-dependent reactive oxygen species-c-jun N-terminal kinase signaling in hepatocellular carcinoma
- (2019) Jia-Ru Wu et al. Oncogenesis
- NK Cell Metabolism and Tumor Microenvironment
- (2019) Iñigo Terrén et al. Frontiers in Immunology
- VersicanV1 promotes proliferation and metastasis of hepatocellular carcinoma through the activation of EGFR–PI3K–AKT pathway
- (2019) Guangyan Zhangyuan et al. ONCOGENE
- PD1Hi CD8+ T cells correlate with exhausted signature and poor clinical outcome in hepatocellular carcinoma
- (2019) Jiaqiang Ma et al. Journal for ImmunoTherapy of Cancer
- HIF-2α upregulation mediated by hypoxia promotes NAFLD-HCC progression by activating lipid synthesis via the PI3K-AKT-mTOR pathway
- (2019) Jianxu Chen et al. Aging-US
- PI3K Inhibitors in Breast Cancer Therapy
- (2019) Haley Ellis et al. Current Oncology Reports
- Efficacy of Regorafenib in Hepatocellular Carcinoma Patients: A Systematic Review and Meta-Analysis
- (2019) Antonio Facciorusso et al. Cancers
- MCUR1-Mediated Mitochondrial Calcium Signaling Facilitates Cell Survival of Hepatocellular Carcinoma via Reactive Oxygen Species-Dependent P53 Degradation
- (2018) Tingting Ren et al. ANTIOXIDANTS & REDOX SIGNALING
- Telomere length and reactive oxygen species levels are positively associated with a high risk of mortality and recurrence in hepatocellular carcinoma
- (2018) Eunkyong Ko et al. HEPATOLOGY
- Effects of the gut–liver axis on ischaemia-mediated hepatocellular carcinoma recurrence in the mouse liver
- (2018) Lorenzo A. Orci et al. JOURNAL OF HEPATOLOGY
- Hepatocellular carcinoma
- (2018) Alejandro Forner et al. LANCET
- Amino acid-dependent cMyc expression is essential for NK cell metabolic and functional responses in mice
- (2018) Róisín M. Loftus et al. Nature Communications
- Celecoxib alleviates AKT/c-Met-triggered rapid hepatocarcinogenesis by suppressing a novel COX-2/AKT/FASN cascade
- (2018) Zhenpeng Qiu et al. MOLECULAR CARCINOGENESIS
- Immunometabolism: A novel perspective of liver cancer microenvironment and its influence on tumor progression
- (2018) Qi Zhang et al. WORLD JOURNAL OF GASTROENTEROLOGY
- CARM1 Methylates GAPDH to Regulate Glucose Metabolism and Is Suppressed in Liver Cancer
- (2018) Xing-Yu Zhong et al. Cell Reports
- Emodin Sensitizes Hepatocellular Carcinoma Cells to the Anti-Cancer Effect of Sorafenib through Suppression of Cholesterol Metabolism
- (2018) Young-Seon Kim et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Knockdown of FOXK1 suppresses liver cancer cell viability by inhibiting glycolysis
- (2018) Hong Cui et al. LIFE SCIENCES
- Metabolic network-based stratification of hepatocellular carcinoma reveals three distinct tumor subtypes
- (2018) Gholamreza Bidkhori et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- New liver cancer biomarkers: PI3K/AKT/mTOR pathway members and eukaryotic translation initiation factors
- (2017) Nicole Golob-Schwarzl et al. EUROPEAN JOURNAL OF CANCER
- Akt Signaling Pathway in Macrophage Activation and M1/M2 Polarization
- (2017) Eleni Vergadi et al. JOURNAL OF IMMUNOLOGY
- Rationalizing combination therapies
- (2017) NATURE MEDICINE
- SREBP-regulated lipid metabolism: convergent physiology — divergent pathophysiology
- (2017) Hitoshi Shimano et al. Nature Reviews Endocrinology
- Increased expression of programmed cell death protein 1 on NK cells inhibits NK-cell-mediated anti-tumor function and indicates poor prognosis in digestive cancers
- (2017) Y Liu et al. ONCOGENE
- CC-223 blocks mTORC1/C2 activation and inhibits human hepatocellular carcinoma cells in vitro and in vivo
- (2017) Zichen Xie et al. PLoS One
- TIP30 regulates lipid metabolism in hepatocellular carcinoma by regulating SREBP1 through the Akt/mTOR signaling pathway
- (2017) F Yin et al. Oncogenesis
- Anticancer strategies based on the metabolic profile of tumor cells: therapeutic targeting of the Warburg effect
- (2016) Xi-sha Chen et al. ACTA PHARMACOLOGICA SINICA
- Comparison of hepatocellular carcinoma in Eastern versus Western populations
- (2016) Su Pin Choo et al. CANCER
- Spontaneous Hepatocellular Carcinoma after the Combined Deletion of Akt Isoforms
- (2016) Qi Wang et al. CANCER CELL
- Differential requirement forde novolipogenesis in cholangiocarcinoma and hepatocellular carcinoma of mice and humans
- (2016) Lei Li et al. HEPATOLOGY
- Inactivation of fatty acid synthase impairs hepatocarcinogenesis driven by AKT in mice and humans
- (2016) Lei Li et al. JOURNAL OF HEPATOLOGY
- Effects of orexin A on glucose metabolism in human hepatocellular carcinoma in vitro via PI3K/Akt/mTOR-dependent and -independent mechanism
- (2016) Yuanyuan Liu et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Yap reprograms glutamine metabolism to increase nucleotide biosynthesis and enable liver growth
- (2016) Andrew G. Cox et al. NATURE CELL BIOLOGY
- Co-activation of AKT and c-Met triggers rapid hepatocellular carcinoma development via the mTORC1/FASN pathway in mice
- (2016) Junjie Hu et al. Scientific Reports
- Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
- (2015) Chih-Hao Chang et al. CELL
- CD147 reprograms fatty acid metabolism in hepatocellular carcinoma cells through Akt/mTOR/SREBP1c and P38/PPARα pathways
- (2015) Jibin Li et al. JOURNAL OF HEPATOLOGY
- 6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1–AMPK signalling
- (2015) Ruiting Lin et al. NATURE CELL BIOLOGY
- Differential regulation of mTORC1 by leucine and glutamine
- (2015) J. L. Jewell et al. SCIENCE
- O-GlcNAcylation of G6PD promotes the pentose phosphate pathway and tumor growth
- (2015) Xiongjian Rao et al. Nature Communications
- IL-15–PI3K–AKT–mTOR: A Critical Pathway in the Life Journey of Natural Killer Cells
- (2015) Alaa Kassim Ali et al. Frontiers in Immunology
- Akt Inhibition Enhances Expansion of Potent Tumor-Specific Lymphocytes with Memory Cell Characteristics
- (2014) J. G. Crompton et al. CANCER RESEARCH
- Liver Damage, Inflammation, and Enhanced Tumorigenesis after Persistent mTORC1 Inhibition
- (2014) Atsushi Umemura et al. Cell Metabolism
- CD147 promotes reprogramming of glucose metabolism and cell proliferation in HCC cells by inhibiting the p53-dependent signaling pathway
- (2014) Qichao Huang et al. JOURNAL OF HEPATOLOGY
- Foxp3-mediated inhibition of Akt inhibits Glut1 (glucose transporter 1) expression in human T regulatory cells
- (2014) Samik Basu et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Akt Phosphorylation and Regulation of Transketolase Is a Nodal Point for Amino Acid Control of Purine Synthesis
- (2014) Arindam Saha et al. MOLECULAR CELL
- Functional polarization of tumour-associated macrophages by tumour-derived lactic acid
- (2014) Oscar R. Colegio et al. NATURE
- A highly potent and selective Vps34 inhibitor alters vesicle trafficking and autophagy
- (2014) Baptiste Ronan et al. Nature Chemical Biology
- PI3K and cancer: lessons, challenges and opportunities
- (2014) David A. Fruman et al. NATURE REVIEWS DRUG DISCOVERY
- A class II phosphoinositide 3-kinase plays an indispensable role in hepatitis C virus replication
- (2013) Tomohiko Maehama et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Synergistic antitumour activity of sorafenib in combination with tetrandrine is mediated by reactive oxygen species (ROS)/Akt signaling
- (2013) J Wan et al. BRITISH JOURNAL OF CANCER
- The mTOR pathway in hepatic malignancies
- (2013) Mamatha Bhat et al. HEPATOLOGY
- MicroRNA-26a Inhibits Angiogenesis by Down-Regulating VEGFA through the PIK3C2α/Akt/HIF-1α Pathway in Hepatocellular Carcinoma
- (2013) Zong-Tao Chai et al. PLoS One
- Stimulation of de Novo Pyrimidine Synthesis by Growth Signaling Through mTOR and S6K1
- (2013) I. Ben-Sahra et al. SCIENCE
- TGF-β-miR-34a-CCL22 Signaling-Induced Treg Cell Recruitment Promotes Venous Metastases of HBV-Positive Hepatocellular Carcinoma
- (2012) Pengyuan Yang et al. CANCER CELL
- Nrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic Reprogramming
- (2012) Yoichiro Mitsuishi et al. CANCER CELL
- MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma
- (2012) YuXiang Fang et al. HEPATOLOGY
- Combined targeting of AKT and mTOR synergistically inhibits proliferation of hepatocellular carcinoma cells
- (2012) Nicole Grabinski et al. Molecular Cancer
- The translational landscape of mTOR signalling steers cancer initiation and metastasis
- (2012) Andrew C. Hsieh et al. NATURE
- Fasting Cycles Retard Growth of Tumors and Sensitize a Range of Cancer Cell Types to Chemotherapy
- (2012) C. Lee et al. Science Translational Medicine
- Protein Kinase B Controls Transcriptional Programs that Direct Cytotoxic T Cell Fate but Is Dispensable for T Cell Metabolism
- (2011) Andrew N. Macintyre et al. IMMUNITY
- Are there opportunities for chemotherapy in the treatment of hepatocellular cancer?
- (2011) Uzma Asghar et al. JOURNAL OF HEPATOLOGY
- Intracellular reactive oxygen species are essential for PI3K/Akt/mTOR-dependent IL-7-mediated viability of T-cell acute lymphoblastic leukemia cells
- (2011) A Silva et al. LEUKEMIA
- Expansion of Hepatic Tumor Progenitor Cells in Pten-Null Mice Requires Liver Injury and Is Reversed by Loss of AKT2
- (2010) Vivian A. Galicia et al. GASTROENTEROLOGY
- Increased Lipogenesis, Induced by AKT-mTORC1-RPS6 Signaling, Promotes Development of Human Hepatocellular Carcinoma
- (2010) Diego F. Calvisi et al. GASTROENTEROLOGY
- Tetrandrine induces apoptosis by activating reactive oxygen species and repressing Akt activity in human hepatocellular carcinoma
- (2010) Chaoyang Liu et al. INTERNATIONAL JOURNAL OF CANCER
- Inhibition of Akt signaling in hepatoma cells induces apoptotic cell death independent of Akt activation status
- (2010) Francesca Buontempo et al. INVESTIGATIONAL NEW DRUGS
- mTOR signaling and drug development in cancer
- (2010) Janet Dancey Nature Reviews Clinical Oncology
- The emerging mechanisms of isoform-specific PI3K signalling
- (2010) Bart Vanhaesebroeck et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- HBx-induced reactive oxygen species activates hepatocellular carcinogenesisviadysregulation of PTEN/Akt pathway
- (2010) Hye-Lin Ha WORLD JOURNAL OF GASTROENTEROLOGY
- AKT-Independent Signaling Downstream of Oncogenic PIK3CA Mutations in Human Cancer
- (2009) Krishna M. Vasudevan et al. CANCER CELL
- PD-L1 regulates the development, maintenance, and function of induced regulatory T cells
- (2009) Loise M. Francisco et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
- (2009) M. G. Vander Heiden et al. SCIENCE
- Akt Determines Replicative Senescence and Oxidative or Oncogenic Premature Senescence and Sensitizes Cells to Oxidative Apoptosis
- (2008) Veronique Nogueira et al. CANCER CELL
- Arginine Deprivation as a Targeted Therapy for Cancer
- (2008) L. Feun et al. CURRENT PHARMACEUTICAL DESIGN
- Epigenetic Changes Induced by Reactive Oxygen Species in Hepatocellular Carcinoma: Methylation of the E-cadherin Promoter
- (2008) Seung-Oe Lim et al. GASTROENTEROLOGY
- Pivotal Role of mTOR Signaling in Hepatocellular Carcinoma
- (2008) Augusto Villanueva et al. GASTROENTEROLOGY
- The Genomic Analysis of Lactic Acidosis and Acidosis Response in Human Cancers
- (2008) Julia Ling-Yu Chen et al. PLoS Genetics
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now